AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spaide, J. K.
Right arrow Articles by Himwich, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spaide, J. K.
Right arrow Articles by Himwich, H. E.
Agricola
Right arrow Articles by Spaide, J. K.
Right arrow Articles by Himwich, H. E.

American Journal of Clinical Nutrition, Vol 24, 1053-1059, Copyright © 1971 by The American Society for Clinical Nutrition, Inc.

Plasma amino acids in schizophrenic patients with methionine or cysteine loading and a monoamine oxidase inhibitor

Joanne K. Spaide M.S.1, Jimmie M. Davis M.S.1, and Harold E. Himwich M.D.1

1 From the Thudichum Psychiatric Research Laboratory, Galesburg State Research Hospital, Galesburg, Illinois 61401

The plasma amino acid levels in four male chronic schizophrenic patients were determined during: a control period, loading with dl-methionine (in three patients only), and then in turn with l-cysteine, tranylcypromine, tranylcypromine plus l-cysteine, and 15 days after the final loading period. The administration of dl-methionine and of l-cysteine markedly increased the total amino acid levels in the blood of the three patients who had received dl-methionine. Tranylcypromine alone did not affect the amino acid levels. When tranylcypromine was given with l-cysteine, an increase in the total amino acid concentration occurred in all four patients, but was slight in the patient who had not received dl-methionine. Therefore, the continued striking elevations observed in the three patients receiving dl-methionine were attributed chiefly to the greater toxicity of dl-methionine as compared with that of l-cysteine. A temporal relationship between behavioral worsening and high total amino acid levels was noted, but exacerbation of psychotic symptoms correlated better with the appearance of urinary psychotomimetic N-dimethyltryptamines (7, 13, 15, 16).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by The American Society for Nutrition